Su et al. point to the diagnostic utility of evaluating polymorphic variations and mutations in the gene coding titin and using this knowledge in the context of immunotherapy of patients suffering from non-small cell lung cancer [78]. Here, TTN is linked to non-small cell lung carcinoma.